Ces Urol 2024, 28(2):113-116 | DOI: 10.48095/cccu2024014

Everolimus in treatment of bilateral giant angiomyolipomas

Kristýna Blažková1, Vladimír Šámal1, Igor Richter2, Vít Paldus1
1 Urologické oddělení, Krajská nemocnice Liberec, a. s.
2 Komplexní onkologické centrum, Krajská nemocnice Liberec, a. s.

Blažková K, Šámal V, Richter I, Paldus V. Everolimus in treatment of bilateral giant angiomyolipomas. The case study highlights the possibility of pharmacological therapy with everolimus for patients with extensive kidney angiomyolipomatosis, which poses a serious risk of bleeding to the patients.

Keywords: Angiomyolipoma, everolimus, superselective embolization, Wunderlich's syndrome.

Received: April 30, 2024; Revised: May 27, 2024; Accepted: May 28, 2024; Prepublished online: May 28, 2024; Published: July 1, 2024 


References

  1. Ürge T, Pitra T, Chudáček Z, et al. Nové trendy v léčbě renálního angiomyolipomu. Ces Urol. 2015; 19(2): 106-117.
  2. Citak EC, Yilmaz EB, Yaman E, et al. Malignant epitheloid angiomyolipoma of the kidney in a child treated with sunitinib, everolimus and axitinib. Can Urol Assoc J. 2015; 9(7-8):E542-5. Go to original source... Go to PubMed...
  3. Paldus V, Šámal V, Mečl J. Wunderlichův syndrom - soubor pacientů s netraumatickým spontánním krvácením do retroperitonea. Ces Urol. 2019; 23(3): 230-236.
  4. Bocková J, Kuldan R. Spontánní ruptura renálního angiomyolipomu. Ces Urol. 2017; 21(2): 172-175.
  5. Geynisman DM, Kadow BT, Shuch BM, et al. Sporadic Angiomyolipomas Growth Kinetics While on Everolimus: Results of a Phase II Trial. J Urol. 2020; 204(3): 531-537. Go to original source... Go to PubMed...
  6. Lee L, Ito T, Jensen RT. Everolimus in the treatment of neuroendocrine tumors: efficacy, sideeffects, resistance, and factors affecting its place in the treatment sequence. Expert Opin Pharmacother. 2018 Jun; 19(8): 909 -928. Go to original source... Go to PubMed...
  7. Bissler JJ, Kingswood JC, Radzikowska E, et al. Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study. PLoS One. 2017; 12(8): e0180939. Go to original source... Go to PubMed...
  8. Luo C, Ye WR, Zu XB, et al. Low-Dose Everolimus Maintenance Therapy for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex. Front Med (Lausanne). 2021; 8: 744050. Go to original source... Go to PubMed...





Web časopisu Česká urologie je určen pouze pro lékaře a odborníky
z oblasti medicíny nebo farmacie.



Beru na vědomí, že informace zveřejněné na těchto stránkách
nejsou určeny pro laickou veřejnost.



Odejít Vstoupit